Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Handa Oncology
Entity

Handa Oncology

Tracked across 1 events · 6 articles · First seen Jul 31, 2026 · Last active Jul 31, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 70
Regulatory
FDA tentative approval for OMCAZIO capsules
Impact: Handa Oncology, the U.S. subsidiary, is the recipient of the tentative approval and will be responsible for commercializing OMCAZIO in the United States.
Jul 31, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Handa Oncology live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.